1. Bogachev SS, Proskurina AS, Gvozdeva TS, Potter EA, Dolgova EV, Orishchenko KE, Nikollin VP, Popova NA, Chernukh ER, Ostanin AA, Leplina OYu, Varaksin NA, Ryabicheva TG, Dvornichenko VV, Ponomarenko DM, Sidorov SV. Results of phase II clinical trials of Panagen preparation and 5-year disease-free survival of patients involved in the study. Ross. Bioter. Zh. 2016;15(1):13-14. Russian.
2. Borodin YuI. Lymphology in Siberia: some results and perspectives. Byull. Sib. Otdel. Ross. Akad. Med. Nauk. 2007;27(2):54-59. Russian.
3. Volkova MS, Astashov VV, Kazakov OV, Larionov PM, Chepik VI. Investigation of lymph nodes at experimental cancerogenesis of mammary gland. Vestn. Novosib. Gos. Univer. Ser.: Biologiya, Klin. Med. 2011;9(1):152-158. Russian.
4. Poveshchenko AF, Kazakov OV, Orlov NB, Poveshchenko OV, Kim II, Bondarenko NA, Solovieva IG, Strunkin DN, Kabakov AV, Rayter TV, Lykov AP, Bogachev SS, Pokushalov EA, Konenkov VI. Lymph cytokines as markers oncogenesis and effective treatment of experimental breast cancer Wistar rat. Patol. Fiziol. Eksp. Ter. 2016;60(3):68-75. Russian.
5. Proskurina AS, Alyamkina EA, Dolgova EV, Nikolin VP, Popova NA, Gvozdeva TS, Orishchenko KE, Sidorov SV, Chernykh ER, Ostanin AA, Leplina OYu, Dvornichenko VV, Ponomarenko DM, Soldatova GS, Varaksin NA, Ryabicheva TG, Zagrebelnij SN, Rogachev VA, Bogachev SS, Shurdov MA. Leykostimulatory and antitumor effect of the human double-stranded DNA preparation “Panagen” in experiments and clinical trials. I. Leykostimulatory and antitumor effect of the preparation “Panagen” in experiments. Vestn. Novosib. Gos. Univer. Ser.: Biologiya, Klin. Med. 2013;11(4):67-82. Russian.